Sean Smith - Mar 2, 2022 Form 4 Insider Report for Neoleukin Therapeutics, Inc. (NLTX)

Role
Principal Accounting Officer
Signature
/s/ Sean M. Smith
Stock symbol
NLTX
Transactions as of
Mar 2, 2022
Transactions value $
$0
Form type
4
Date filed
3/3/2022, 03:39 PM
Next filing
Aug 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NLTX Stock Option (Right to Buy) Award $0 +80K $0.00 80K Mar 2, 2022 Common Stock 80K $2.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option will vest on March 2, 2023, and 1/48 of the shares subject to the option will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.